Evidence-based clinical pathways might be able to reduce overall spending on cancer care without compromising quality. According to a new study, an oncology pathways program could save about 15% on ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma We conducted a retrospective ...

Will giving oncologists financial incentives to "stay on track" help reign in cancer costs? At least one insurer, and maybe more in the future, are counting on it. WellPoint, one of the largest health ...

UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...